Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

INTRODUCTION: treatments targeting the Human Epidermal Growth Factor Receptor 2 (HER2/ERBB2) have improved the natural history of HER2-positive breast cancer. However, except HER2 protein expression and gene amplification, there is no predictive biomarker to guide the HER2-targeted therapies. We dev...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Guerin, Mathilde, Gonçalves, Anthony, Toiron, Yves, Baudelet, Emilie, Pophillat, Matthieu, Granjeaud, Samuel, Fourquet, Patrick, Jacot, William, Tarpin, Carole, Sabatier, Renaud, Agavnian, Emilie, Finetti, Pascal, Adelaide, José, Birnbaum, Daniel, Ginestier, Christophe, Charafe-Jauffret, Emmanuelle, Viens, Patrice, Bertucci, François, Borg, Jean-Paul, Camoin, Luc
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2018
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173470/
https://ncbi.nlm.nih.gov/pubmed/30333908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26031
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍